RxDoctor Payments Data

Julia Elrod

Family · Clinton, INNPI 1588327878

Payments from drug & device makers

$3,467in general payments, 2019–2025

Across 134 payments — averaging $25.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$781
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$506
  • Lilly USA, LLC$308
  • Amgen$306
  • Novo Nordisk$218
  • AstraZeneca$138
  • plus $1K from 16 others

What the payments were for

  • Food & beverage$3,455100%
  • Education$120%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,467 in reported general payments places this provider in the 85th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide47$60,505
JardianceEmpagliflozin14$17,902
MounjaroTirzepatide11$11,768
Diclofenac Sodium ErDiclofenac Sodium30$1,069
Alprazolam68$753
Ezetimibe28$680
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav97$670
Pantoprazole Sodium33$605
Albuterol Sulfate HfaAlbuterol Sulfate28$595
Levothyroxine Sodium59$547
Omeprazole35$529
Pregabalin14$468
Potassium Chloride13$419
Ondansetron Hcl26$397
Gabapentin41$373

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$218$60,50547 claims
Boehringer IngelheimJardiance$90$17,90214 claims
Lilly USA, LLCMounjaro$308$11,76811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,392 family providers in Indiana.

Other family in Clinton

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →